ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ONXX Onyx Pharmaceuticals, Inc. (MM)

124.70
0.00 (0.00%)
22 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Onyx Pharmaceuticals, Inc. (MM) NASDAQ:ONXX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 124.70 0 01:00:00

Onyx Pharmaceuticals to Report First Quarter 2013 Financial Results After Market on May 7, 2013

16/04/2013 9:00pm

Marketwired


Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Onyx Pharmaceuticals, Inc. (MM) Charts.

Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced that it will report financial results for the first quarter 2013 ended March 31, 2013 after market closes on Tuesday, May 7, 2013. The company will host a webcast and conference call with management to discuss financial results, as well as provide a general business overview, at 5:00 p.m. ET (2:00 p.m. PT).

To access a live audio webcast of the conference call, log onto the company's website at: http://www.onyx.com/investors/event-calendar.

To access the live conference call, dial 847-585-4405 and use the passcode 34676954#. A replay of the call will be available on the Onyx website or by dialing 630-652-3042 and using the passcode 34679654# approximately one hour after the conference call concludes through May 21, 2013.

About Onyx Pharmaceuticals, Inc. Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer. The company is focused on developing novel medicines that target key molecular pathways. For more information about Onyx, visit the company's website at www.onyx.com.

1 Year Onyx Pharmaceuticals, Inc. (MM) Chart

1 Year Onyx Pharmaceuticals, Inc. (MM) Chart

1 Month Onyx Pharmaceuticals, Inc. (MM) Chart

1 Month Onyx Pharmaceuticals, Inc. (MM) Chart

Your Recent History

Delayed Upgrade Clock